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Introduction {#sec1}
============

Most eukaryotic cells have a diploid cell cycle in which chromosomes are replicated only once during each cell division to generate two identical 2n daughter cells. Nevertheless, certain organisms can undergo successive rounds of genome duplication in the absence of cytokinesis to acquire a polyploid status that can involve the whole organism or just specific tissues and organs ([@bib20], [@bib25], [@bib70]). Among mammals, including humans, polyploidy is particularly relevant in the liver hepatocytes, megakaryocytes, and placental giant trophoblast cells, although it also takes place in the heart and muscle ([@bib28], [@bib34]). In the liver, the percentage of polyploid hepatocytes ranges from 80% to 90% in rats, to 30% in humans, and to close to 50% in mice ([@bib10], [@bib19]). Polyploidy does not seem to be a uniform phenomenon, and usually aneuploid cells with altered number of chromosomes co-exist with cells having ≥2n DNA content ([@bib70]). Several mechanisms have been proposed to explain physiological polyploidy, including failure to complete cytokinesis after mitosis of diploid hepatocytes ([@bib33]), cell fusion of placental cells, or endomitosis in megakaryocytes ([@bib76], [@bib83]). Recent reports have suggested that polyploidization may not be an irreversible process since mouse hepatocytes with one-half chromosomal content can be obtained from polyploid liver cells by artificial cell fusion ([@bib18], [@bib79]). Such phenomena would then generate mixed cell populations with dissimilar number of chromosomes by a process named ploidy conveyor ([@bib19]).

Physiological polyploidy takes place in the mouse liver right after the transition from preweaning (approximately 3 weeks after birth) to adulthood ([@bib48], [@bib57], [@bib56]). During this period, immature hepatoblasts start to differentiate into mature hepatocytes concomitantly with a reduction in their proliferative ability ([@bib32], [@bib71]). From a functional perspective, polyploidy induces a terminal differentiated phenotype that increases cell size, amplifies gene expression, helps tissue organization, and modifies hepatic metabolism ([@bib70], [@bib83]). In fact, transcriptomic studies have revealed that larger polyploid hepatocytes switch their metabolism from mitochondrial oxidative phosphorylation to glycolysis to adapt to metabolic stresses, although some controversy exists on the relative contribution of ploidy versus cell size in their metabolic reprogramming ([@bib51]). The liver is exposed to the deleterious effects of endo- and xenobiotics and, as such, has the remarkable property to regenerate upon injury ([@bib75]). Polyploid hepatocytes can therefore trigger a response against toxic compounds by entering mitosis and generating proliferative hepatocytes that will reconstitute the damaged parenchyma ([@bib17]). Importantly, several human cancers seem to contain polyploid cells that can re-enter cell cycle acquiring Warburg-like glycolytic metabolism and contributing to tumor growth ([@bib16], [@bib26], [@bib82]).

The aryl hydrocarbon/dioxin receptor (AhR) has many different physiological and homeostatic functions some of which are now beginning to emerge. Mouse models have shown that complete AhR depletion alters the development and function of several organs, including the liver, heart, skin, and immune system ([@bib22], [@bib54], [@bib59], [@bib61], [@bib68]). Despite early studies showing that adult AhR-null mice (*AhR−/−*) have smaller livers ([@bib23], [@bib24], [@bib69]) with embryo-derived intrahepatic portosystemic shunt ([@bib41], [@bib69]), there are no studies exploring how AhR affects liver maturation and differentiation during the critical postnatal to adulthood developmental window.

In this work, we have investigated whether AhR is needed for the diploid-to-polyploid conversion that takes place during the transition from an immature to an adult liver. AhR deficiency severely compromised the generation of polyploid hepatocytes and maintained a more proliferative liver under physiological conditions. Persistent upregulation of signaling pathways controlling survival, proliferation, and metabolism in adult AhR-null liver likely compromised polyploidization and favored a diploid and undifferentiated phenotype. Such attributes could greatly influence the regenerative competence of the *AhR−/−* liver in the short term as well as its increased ability to develop hepatocarcinomas upon carcinogen exposure in the long term ([@bib85]). Thus, AhR is a relevant component of a complex signaling network controlling physiological liver polyploidy and differentiation. Selective AhR modulators may be useful to regulate ploidy-related liver responses such as those required for regeneration after toxic damage or surgical intervention or for inhibition of tumor progression.

Results {#sec2}
=======

AhR Deficiency Increases Liver Cellularity and Proliferation and Impairs Adult Polyploidy {#sec2.1}
-----------------------------------------------------------------------------------------

Early reports showed that AhR-null mice (*AhR−/−*) have developmental hepatic alterations, including a reduced organ size ([@bib23], [@bib69]). In this work, we have used mice around the time of weaning (25 days of age, hereafter preweaning) and adult mice (9--10 weeks of age) having or lacking AhR expression. Histological examination of liver sections from preweaning and adult *AhR−/−* mice suggested an increase in cellularity with respect to age-matched *AhR+/+* mice ([Figure 1](#fig1){ref-type="fig"}A), despite the smaller liver size of AhR-null preweaning mice ([Figure 1](#fig1){ref-type="fig"}B). Adult *AhR−/−* mice also have a significant reduction in liver size and weight as previously reported ([@bib23], [@bib69]). This *de visu* observation was confirmed by cell counting and, indeed, *AhR−/−* livers had significantly higher numbers of hepatocytes than *AhR+/+* livers at preweaning and adult age ([Figure 1](#fig1){ref-type="fig"}C). Cellularity in adults was reduced with respect to preweaning livers regardless of mice genotype, possibly because of a normal developmental process that decreased cell proliferation and increased cell growth ([Figure 1](#fig1){ref-type="fig"}C). Accordingly, the average nuclear area of 4\',6-diamidino-2-phenylindole (DAPI)-stained *AhR−/−* hepatocytes was significantly smaller in both preweaning and adult livers ([Figure 1](#fig1){ref-type="fig"}D). In addition, the nuclei of preweaning hepatocytes were smaller than those of adult mice, irrespective of AhR expression ([Figure 1](#fig1){ref-type="fig"}D). Liver maturation involves several important cytological changes, including the appearance of binucleated and mononucleated polyploid hepatocytes ([@bib31], [@bib70], [@bib83]). Interestingly, confocal fluorescence microscopy of DAPI-stained liver sections revealed that whereas binucleated hepatocytes accounted for 25%--30% of liver cells in adult *AhR+/+* mice, they represented only about 10% of liver cells in aged-matched *AhR−/−* mice ([Figure 1](#fig1){ref-type="fig"}E). Binucleated hepatocytes were less abundant in preweaning mice and, in particular, in those lacking AhR expression ([Figure 1](#fig1){ref-type="fig"}E).Figure 1AhR-Null Liver has Hypercellularity, Increased Nuclear Size, and Reduced Number of Binucleated Hepatocytes(A) Livers were collected from preweaning and adult *AhR+/+* and *AhR−/−* mice, fixed, embedded in paraffin, sectioned, and stained with hematoxylin and eosin (H&E).(B) Relative liver weight was obtained in preweaning mice relative to the total body weight of each animal.(C) Liver cellularity was quantified in tissue sections obtained from preweaning and adult AhR mice of each genotype.(D) Nuclear area of hepatocytes was determined in *AhR+/+* and *AhR−/−* liver sections from preweaning and adult mice after staining with DAPI. ImageJ software was used.(E) Binucleated cells in preweaning and adult *AhR+/+* and *AhR−/−* livers were quantified by confocal fluorescence microscopy using DAPI-stained sections. Six mice for each developmental time and genotype and three technical replicates were analyzed.Data are shown as mean ± SD. Scale bar, 50 μm; scale bar in inset, 50 μm. Nuclear area is represented as the integrated density (IntDen) measured by the ImageJ software in micrographs taken at the same magnification and resolution. SD, standard deviation.

Altogether, these results suggested that lack of AhR could compromise physiological control of hepatocyte proliferation and the preweaning-to-adult transition in mouse liver. We then decided to analyze if the AhR-null phenotype could involve altered polyploidization since an increase in ploidy reduces proliferation and induces differentiation in the liver ([@bib16], [@bib29], [@bib76]). Flow cytometry analysis of the DNA content of primary hepatocytes isolated from preweaning mice revealed that most cells were diploid (2c) in both *AhR+/+* and *AhR−/−* livers and that the amount of tetraploid (4c) and octaploid (8c) cells was minimal ([Figures 2](#fig2){ref-type="fig"}A, 2C, and [S1](#mmc1){ref-type="supplementary-material"}). By contrast, adult *AhR+/+* livers became significantly enriched in 4c and 8c hepatocytes, whereas such enrichment was not found in *AhR−/−* hepatocytes, which remained mostly diploid ([Figures 2](#fig2){ref-type="fig"}B and 2D). A marked asymmetry in polyploidy was therefore observed between adult *AhR+/+* and *AhR−/−* livers ([Figure 2](#fig2){ref-type="fig"}E) that did not appear to be due to a significant level of endogenous apoptotic cell death ([Figure 2](#fig2){ref-type="fig"}F). Therefore, AhR controls normal liver architecture and cellularity and the nuclear content and ploidy of hepatocytes. Since polyploidization is related to liver differentiation, we next examined changes in albumin levels in preweaning and adult mice. Indeed, albumin messenger RNA (mRNA) ([Figure 2](#fig2){ref-type="fig"}G) and protein ([Figure 2](#fig2){ref-type="fig"}H) levels were significantly downregulated in *AhR−/−* livers at either developmental stage, suggesting that AhR expression is needed for physiological liver maturation.Figure 2AhR Deficiency Impairs Liver Polyploidy in the Absence of Increased Apoptosis(A--D) Primary hepatocytes were isolated from preweaning (A and C) and adult (B and D) *AhR+/+* and *AhR−/−* mice by collagenase liver perfusion. Cells were fixed, stained with propidium iodide, and their DNA content analyzed by flow cytometry in a MACSQuant VYB flow cytometer. Peaks correspond to diploid (2c), tetraploid (4c), and octaploid (8c) hepatocytes (red arrows).(E) Cell subpopulations with different ploidy status were quantified and their percentages represented. Percentage of cells at the S phase (2c-to-4c and 4c-to-8c) transitions are also indicated.(F) Apoptotic cells in adult *AhR−/−* livers were quantified and normalized by those of *AhR+/+* mice.(G and H) Albumin mRNA (G) and protein (H) expression was determined in liver tissue from preweaning and adult *AhR+/+* and *AhR−/−* mice. mRNA gene expression was normalized by *Gapdh* and represented as 2^−ΔΔCt^.Six *AhR+/+* and seven *AhR−/−* mice were analyzed for each developmental time and four technical replicates were performed. Data are shown as mean ± SD. n.s., Not statistically significant; SD, standard deviation. Antibodies and oligonucleotides used are indicated in [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}, respectively. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

AhR is known to regulate cell cycle progression by interacting with retinoblastoma protein (RB) and blocking E2F-dependent transcription of target genes such as Cyclin E ([@bib27], [@bib52], [@bib59], [@bib62]). AhR activation by TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) also increases tumor suppressor p27^Kip1^, which, in turn, inactivates Cyclin E ([@bib38], [@bib73]). We then decided to analyze cell proliferation in mice liver *in vivo*. Ki67 staining of preweaning livers revealed high rates of cell proliferation in both genotypes, the number of proliferating cells being much higher in the absence of AhR than in control mice ([Figure 3](#fig3){ref-type="fig"}A). For adults, multiphoton confocal microscopy was used on tissue sections stained for the proliferating cell nuclear antigen (PCNA) because of the low rates of cell proliferation usually present in the matured liver. Although cell proliferation was markedly reduced with aging, *AhR−/−* livers still had more proliferative cells than *AhR+/+* livers ([Figure 3](#fig3){ref-type="fig"}A). Such increased proliferative potential of *AhR−/−* hepatocytes was associated with a higher number of cells passing through the G0/G1 (2c) and G2/M (4c) phases of the cell cycle, as determined by flow cytometry examination of freshly isolated primary hepatocytes ([Figure 3](#fig3){ref-type="fig"}B). Surprisingly, however, cell cycle regulators Cyclin B1 (G2/M) and Cyclin E (G1/S) were downregulated in liver from preweaning *AhR−/−* mice when compared with *AhR+/+* mice ([Figures 3](#fig3){ref-type="fig"}C and 3D). An opposite pattern of expression was observed in adult mice because both Cyclin B1 and Cyclin E were upregulated in AhR-null livers ([Figures 3](#fig3){ref-type="fig"}C and 3D). In addition, the expression of cyclin-dependent kinase inhibitory protein p27^Kip1^ was markedly reduced in preweaning and adult *AhR−/−* livers ([Figure 3](#fig3){ref-type="fig"}E). No significant differences in Cyclin D1 (G1/S) were found between *AhR+/+* and *AhR−/−* livers at any developmental stage (not shown). These results suggest that high Cyclin B1 and Cyclin E expression, in parallel to reduced p27^Kip1^ levels, could maintain proliferation and inhibit polyploidy in *AhR−/−* liver, in agreement with the role of Cip/Kip proteins in promoting differentiation and polyploidy in mammalian cells ([@bib76]). We next determined if the preweaning-to-adult transition involved changes in AhR expression. Immunoblotting analysis revealed that AhR protein levels were significantly lower in adult livers than in *AhR+/+* preweaning livers; AhR protein remained undetectable at any developmental stage in *AhR−/−* mice ([Figure 3](#fig3){ref-type="fig"}F).Figure 3AhR-Null Livers Have Increased Proliferation and Changes in Cell Cycle Regulators Cyclin E and p27^Kip1^(A) *In vivo* proliferation was determined in Ki67-stained tissue sections from preweaning *AhR+/+* and *AhR−/−* mouse liver. Adult livers from *AhR+/+* and *AhR−/−* mice were analyzed by confocal multiphoton microscopy using tissue sections stained for the proliferating cell nuclear antigen (PCNA). An Olympus FV1000 confocal microscope (Olympus) equipped with a multiphoton unit was used. Arrowheads mark proliferation positive hepatocytes.(B) Primary hepatocytes were isolated from adult AhR wild-type and AhR-null mice by collagenase perfusion and freshly analyzed for cell cycle distribution by flow cytometry after staining with propidium iodide. Fraction of cells in G0/G1 (2c), S (2 \< c \> 4), and G2/M (4c) are represented. A Cytomics FC500 equipment was used.(C--E) Total protein was obtained from preweaning and adult *AhR+/+* and *AhR−/−* livers and analyzed by immunoblotting for Cyclin B1 (C), Cyclin E (D), and p27^Kip1^ (D) using specific antibodies.(F) AhR protein expression was also analyzed in preweaning (PW) and adult (AD) liver extracts from *AhR+/+* and *AhR−/−* by immunoblotting. β-Actin was used to confirm protein integrity and equal loading.Two representative mice for each experimental condition are shown. Seven mice for each developmental time and genotype and three technical replicates were analyzed. Data are shown as mean ± SD. n.s., Not statistically significant; SD, standard deviation. Scale bar, 50 μm. Antibodies used are indicated in [Table S1](#mmc1){ref-type="supplementary-material"}.

Persistent INS-R/PI3K-Dependent Signaling and Sustained ERK1/2 Activation in Non-polyploid AhR-Null Livers {#sec2.2}
----------------------------------------------------------------------------------------------------------

To investigate the possible signaling networks that could mediate the AhR-null liver phenotype, we first focused on the insulin receptor (INS-R) and its downstream PI3K (phosphatidylinositol-3-phosphate kinase) pathway since it is a critical regulator of cell viability, proliferation, and eventually, ploidy ([@bib10], [@bib81]). INS-R protein levels did not significantly differ between *AhR+/+* and *AhR−/−* livers in preweaning or adult mice ([Figure 4](#fig4){ref-type="fig"}A). Although liver maturation seemed to involve a reduction in INS-R expression, it was AhR independent ([Figure 4](#fig4){ref-type="fig"}A). Notably, activation of the major INS-R intermediate protein in the liver phospho-IRS-2 (insulin receptor substrate-2) was significantly higher in *AhR−/−* than in *AhR+/+* mice at both preweaning and adult age ([Figure 4](#fig4){ref-type="fig"}B), suggesting that despite similar receptor levels INS-R signaling might be increased in the absence of AhR. We next decided to address whether INS-R/IRS-2 overactivation was functionally relevant in modulating PI3K signaling in *AhR−/−*liver. The expression levels of the PI3K regulatory subunit, which interacts with phospho-IRS-2, p85α, were significantly increased in preweaning and adult *AhR−/−* livers when compared with *AhR+/+* livers ([Figure 4](#fig4){ref-type="fig"}C).Figure 4Insulin Receptor Signaling Is Altered in AhR-null Livers and the INS-R/PI3K Pathway May Contribute to the Increased Proliferative Potential of *AhR−/−* Livers(A) Protein expression of the insulin receptor (INS-R) was analyzed by immunoblotting in liver extracts from preweaning (PW) and adult (AD) *AhR+/+* and *AhR−/−* mice.(B) Activation of the INS-R signaling intermediate IRS-2 was quantified by an enzyme-linked immunosorbent assay (ELISA) kit that detects the phosphorylated form of the protein. A positive control was performed using mice treated with insulin.(C) Protein levels of IRS-2 downstream intermediate p85-PI3K were determined by immunoblotting using the experimental conditions indicated above.(D and E) Immunoblotting using specific antibodies was used to analyze activation levels of molecular intermediates of the INS-R/PI3K pathway: AKT (total AKT and p-AKT^Ser473^) (D) and GSK3β (total GSK3β and p-GSK3β^Ser9^) (E).(F) Protein levels of the PI3K-negative regulator PTEN were also analyzed by immunoblotting. β-Actin was used to confirm protein integrity and equal loading.Two representative mice for each experimental condition are shown. Ten mice for each developmental time and genotype and three to four technical replicates were analyzed. Data are shown as mean ± SD. n.s., Not statistically significant; SD, standard deviation. Antibodies used are indicated in [Table S1](#mmc1){ref-type="supplementary-material"}.

Serine-threonine protein kinase-B/AKT (hereinafter AKT) is the required PI3K signaling intermediate in most cell types ([@bib81]). Total protein levels of AKT were not affected by AhR expression at any of the developmental times analyzed. However, active phospho-AKT (p-AKT^Ser473^) was significantly upregulated by AhR deficiency in both preweaning and adult livers, and total levels in adults exceed those in preweaning mice ([Figure 4](#fig4){ref-type="fig"}D). Consistently, p-AKT target protein glycogen synthase kinase-3β (GSK3β) was more efficiently phosphorylated (p-GSK3β^Ser9^) in preweaning and adult *AhR−/−* livers than in their *AhR+/+* counterparts with a pattern closely resembling that of p-AKT ([Figure 4](#fig4){ref-type="fig"}E). PI3K activity and AKT phosphorylation are negatively regulated by the phosphatase and tensin homolog (PTEN) ([@bib5]). Accordingly, PTEN was significantly downregulated in preweaning and adult *AhR−/−* livers with a pattern inverse to that found for p-AKT ([Figure 4](#fig4){ref-type="fig"}F). Altogether, these results suggest that the increased proliferative potential of *AhR−/−* livers may be associated with a sustained overactivation of the INS-R/PI3K pathway. PI3K also signals to the Ras pathway, ultimately regulating the activation of mitogen-activated protein kinases (MAPKs) involved in cell proliferation, including the extracellular signal-regulated kinases 1/2 (ERK1/2) ([@bib7], [@bib74]). We observed that the total levels of ERK1 (ERK1/p44) did not significantly change between *AhR+/+* and *AhR−/−* livers in preweaning or adult mice. However, normalized phosphorylated ERK1/p44 levels (pERK/ERK ratio) increased in the absence of AhR under both developmental conditions ([Figures 5](#fig5){ref-type="fig"}A and 5B). The ERK2/p42 isoform did not show significant differences in normalized phosphorylation levels between AhR wild-type and AhR-null preweaning mice, although it was upregulated in adult *AhR−/−* livers ([Figures 5](#fig5){ref-type="fig"}A and 5C). Thus, sustained PI3K-dependent ERK1/2 signaling may also contribute to altered preweaning-to-adult transition in AhR-deficient liver.Figure 5Liver Maturation Involves Changes in ERK1/2, p53, and p21^Cip1^(A--E) Preweaning (PW) and adult (AD) *AhR+/+* and *AhR−/−* livers were processed to obtain total protein extracts that were analyzed by immunoblotting for total and phosphorylated ERK1/p44 and ERK2/p42 (ERK1/2, p-ERK1/2^Thr202/Tyr204^) (A--C), p53 (D), and p21^Cip1^ (E). β-Actin was used to confirm protein integrity and equal loading. Two representative mice for each experimental condition are shown. Ten mice for each developmental time and genotype and three technical replicates were analyzed. Data are shown as mean ± SD. n.s., Not statistically significant; SD, standard deviation. Antibodies used are indicated in [Table S1](#mmc1){ref-type="supplementary-material"}.

PI3K also signals to inhibit the p53 tumor suppressor to block apoptosis in proliferating cells ([@bib66], [@bib80]). Notably, recent studies have also shown that p53 has relevant functions in preventing polyploidy in mature cells ([@bib2], [@bib40]). We then sought to analyze whether liver maturation involved changes in p53 expression in an AhR-dependent manner. Immunoblotting experiments showed that p53 levels were markedly reduced in preweaning *AhR−/−* livers with respect to *AhR+/+* livers ([Figure 5](#fig5){ref-type="fig"}D). One of the most relevant targets of active p53 is the p21^Cip1^ protein (p21^Cip1^), also involved in repressing cell proliferation ([@bib35], [@bib36]). Accordingly, its expression closely followed that of p53 in preweaning *AhR−/−* and *AhR+/+* livers, being significantly downregulated in AhR-null mice ([Figure 5](#fig5){ref-type="fig"}E). Surprisingly, however, p53 expression was higher in adult *AhR−/−* livers than in age-matched *AhR+/+* livers ([Figure 5](#fig5){ref-type="fig"}D), despite the persistent p21^Cip1^ repression present in AhR-lacking hepatocytes ([Figure 5](#fig5){ref-type="fig"}E). Thus, low p53 levels may allow higher proliferation rates during preweaning in *AhR−/−* mice, whereas its increasing expression in adults could block polyploidy in the absence of a significant inhibitory effect on proliferation.

Lack of Polyploidy in Adult *AhR−/−* Liver Involves Altered Wnt/β-Cat Signaling {#sec2.3}
-------------------------------------------------------------------------------

The PI3K pathway is also linked to Wnt/β-Cat signaling since the AKT downstream target GSK3β is a component of the Wnt/β-Cat degradation complex ([@bib55]). Immunofluorescence analysis by confocal microscopy of liver sections from preweaning mice revealed increased levels and a more abundant nuclear localization of β-Cat in the centrilobular areas of the hepatic parenchyma in *AhR−/−* than in *AhR+/+* mice ([Figure 6](#fig6){ref-type="fig"}A), in agreement with the zonation of β-Cat in the liver ([@bib3], [@bib6]). Immunoblotting of nuclear extracts also showed increased levels of β-Cat in AhR-null preweaning mice ([Figure 6](#fig6){ref-type="fig"}A). The difference in β-Cat expression between *AhR+/+* and *AhR−/−* livers was milder in adult mice, and its overall levels were reduced with respect to preweaning mice of either phenotype ([Figure 6](#fig6){ref-type="fig"}A). Nevertheless, β-Cat was active in adult *AhR−/−* liver since the mRNA expression of its target genes *Axin*, *Cyclin D1*, *c-Myc,* and *Lef1* was increased with respect to *AhR+/+* adult liver ([Figure 6](#fig6){ref-type="fig"}B). Interestingly, co-immunoprecipitation experiments showed that, in fact, AhR may be a component of a protein complex that also includes β-Cat in both preweaning and adult livers ([Figure 6](#fig6){ref-type="fig"}C); no significant co-immunoprecipitation between AhR and β-Cat was detected in preweaning or adult *AhR−/−* livers ([Figure 6](#fig6){ref-type="fig"}C). In addition, β-Cat seemed to also interact in a common protein complex with activated phospho-AKT in preweaning and adult livers and with increased efficiency in *AhR−/−* mice ([Figure 6](#fig6){ref-type="fig"}D). Thus, *in vivo*, upregulated AKT and β-Cat signaling may cooperate to maintain hepatocyte proliferation and to reduce their ploidy in the absence of AhR expression.Figure 6β-Cat Expression and Signaling Are Upregulated in AhR-Deficient Liver and AhR Modulates Wnt/β-Cat-Dependent Transcription in Mouse Primary Hepatocytes(A) Liver tissue was obtained from preweaning and adult *AhR+/+* and *AhR−/−* mice, fixed, embedded in paraffin, sectioned, and analyzed by immunofluorescence for β-Cat expression using a specific primary antibody and an Alexa 633-labeled secondary antibody. Sections were visualized using an Olympus FV1000 confocal microscope (Olympus). DAPI was used to label cell nuclei. Nuclear extracts (A, left panel) and total liver protein (A, right panel) were also analyzed for β-Cat protein levels by immunoblotting using a specific antibody.(B) Total RNA was purified from adult *AhR+/+* and *AhR−/−* liver, reverse transcribed, and mRNA gene expression for the β-Cat target genes *Axin2*, *Cyclin D1,* and *c-Myc* and *Lef1* were quantified by real-time quantitative polymerase chain reaction (qPCR) using the oligonucleotides indicated in [Table S1](#mmc1){ref-type="supplementary-material"}.(C and D) Total liver protein from preweaning (PW) and adult (AD) *AhR+/+* and *AhR−/−* mice was immunoprecipitated for AhR (C) or pAKT (D) and the presence of β-Cat in the complexes detected by immunoblotting using a specific antibody. Adult primary hepatocytes were isolated from *AhR+/+* and *AhR−/−* mice by collagenase perfusion and cultured in complete medium containing HGF and EGF.(E) Adult *AhR+/+* primary hepatocytes were treated with medium from control L1 cells (control), medium from L1-Wnt3a-producing cells (1:4 dilution), or 10 μM FICZ. *AhR−/−* primary hepatocytes were treated with medium from control L1 cells (control) or medium from L1-Wnt3a-producing cells (1:4 dilution). Total RNA was purified and analyzed for *Axin2* or *Cyp1a1* mRNA expression by reverse-transcriptase (RT)-qPCR.(F) Adult primary hepatocytes from *AhR+/+* and *AhR−/−* liver were transfected with the TOP/FOP luciferase system to determine β-Cat-dependent transcription under basal cell conditions or after treatment with L1-Wnt3a conditioned medium (1:4 dilution).(G) The TOP/FOP luciferase assay was also performed in preweaning primary hepatocytes obtained from mice of either genotype. mRNA gene expression was normalized by *Gapdh* and represented as 2^−ΔΔCt^. β-Actin and histone H3 (H3) were used to confirm protein integrity and equal loading. Eight mice for each developmental time and genotype and at least three technical replicates were analyzed.Data are shown as mean ± SD. n.s., Not statistically significant; SD, standard deviation. Scale bar, 50 μm. Antibodies and oligonucleotides used are indicated in [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}, respectively.

To further investigate if AhR modulates Wnt/β-Cat signaling in adult liver, primary hepatocytes were isolated from *AhR+/+* and *AhR−/−* mice by collagenase perfusion and cultured in cell medium containing hepatocyte growth factor (HGF) and epidermal growth factor (EGF). Experiments were done in the presence of conditioned medium enriched in the Wnt/β-Cat ligand Wnt3a or after treatment with the AhR non-toxic agonist 6-formylindolo\[3,2-b\]carbazole (FICZ). mRNA expression of the β-Cat target gene *Axin2* was moderately induced by Wnt3a but not by FICZ in AhR wild-type hepatocytes; by contrast, Wnt3a treatment markedly increased *Axin2* mRNA in AhR-null primary hepatocytes ([Figure 6](#fig6){ref-type="fig"}E). AhR target gene *Cyp1a1* was largely induced by FICZ and significantly by Wnt3a in *AhR+/+* primary hepatocytes; no significant *Cyp1a1* expression was detected in *AhR−/−* primary hepatocytes ([Figure 6](#fig6){ref-type="fig"}E). Thus, the transcriptional activity of AhR can be induced by Wnt/β-Cat signaling in AhR-expressing primary hepatocytes, but not vice versa, and interestingly, AhR-lacking primary hepatocytes were highly responsive to activation of the Wnt/β-Cat pathway. To give additional support to these data, primary hepatocytes from *AhR+/+* and *AhR−/−* livers were transfected with a TOP-Flash reporter construct that allows quantification of β-Cat-dependent transcription. TOP-Flash luciferase activity was higher in adult *AhR−/−* primary hepatocytes under basal culture conditions ([Figure 6](#fig6){ref-type="fig"}F), and more notably after treatment with Wnt3a-enriched medium ([Figure 6](#fig6){ref-type="fig"}F). Transfection of the TOP-Flash reporter construct in preweaning primary hepatocytes also revealed an increase in β-Cat transcriptional activity in *AhR−/−* cells ([Figure 6](#fig6){ref-type="fig"}G).

Conserved mTOR Activation during the Preweaning-to-Adult Transition in the Liver {#sec2.4}
--------------------------------------------------------------------------------

Different signaling pathways controlling cell proliferation, metabolism, and differentiation converge to the mammalian target of rapamycin (mTOR). Particularly relevant are those mediated by PI3K, ERK, and Wnt/β-Cat, which activate the mTORC1 complex through the guanosine triphosphate (GTP)-binding protein RHEB ([@bib42], [@bib43], [@bib67]). We therefore decided to determine whether the sustained activation of those pathways in the preweaning-to-adult transition in *AhR−/−* liver resulted in increased mTORC1 activation. Protein analysis showed that mTOR expression remained at a higher level in both preweaning and adult *AhR−/−* livers when compared with their counterpart *AhR+/+* livers ([Figure 7](#fig7){ref-type="fig"}A). One major target of the mTORC1 complex is the ribosomal S6 kinase-1 (S6K1), which is activated by phosphorylation ([@bib42], [@bib43], [@bib67]). In addition to its functions in protein synthesis, S6K1 has been recently implicated in the control of polyploidy ([@bib46]). The levels of phosphorylated S6K1 were increased in preweaning and adult *AhR−/−* livers when compared with *AhR+/+* liver ([Figure 7](#fig7){ref-type="fig"}B), in agreement with the observed pattern of mTOR expression. Hence, the persistent activation of INS-R/PI3K/ERK and Wnt/β-Cat signaling pathways that takes place during liver maturation in *AhR−/−* mice might assemble at the mTORC1 complex, maintaining proliferation and inhibiting differentiation-related polyploidy.Figure 7mTOR Expression, Ribosomal S6K1 Activation, and Metabolomic Changes during the Preweaning-to-Adult Transition in *AhR−/−* Liver(A) Total protein obtained from preweaning (PW) and adult (AD) *AhR+/+* and *AhR−/−* liver were analyzed for the expression of mTOR by immunoblotting using a specific antibody.(B--D) (B) Protein extracts from the same mice were used to determine by immunoblotting the level of activation of mTORC1 target protein phospho-S6K1 (p-S6K1^Tyr389^). Serum samples were obtained from preweaning (PW) and adult (AD) *AhR+/+* and *AhR−/−* mice, processed, and their metabolites analyzed by chromatographic separation and mass spectrometry. The levels of mTORC1-activating amino acids L-Leu (C) and L-Gln (D) were measured and quantified in both AhR genotypes and developmental stages.(E) Metabolomics were also used to identify and quantify the accumulation of intermediates of the mitochondrial oxidative metabolism succinate, fumarate, and malate in the samples indicated above.(F) Levels of azelaic acid were determined by chromatography and mass spectrometry in serum samples from preweaning *AhR+/+* and *AhR−/−* mice.(G) Protein levels of the hepatic carboxylesterase-3 (CES3) were determined in preweaning *AhR+/+* and *AhR−/−* mice by immunoblotting using a specific antibody. β-Actin was used to confirm protein integrity and equal loading.Two representative mice for each experimental condition are shown. Eight mice (A--D) or six mice (E--F) for each developmental time and genotype and three technical replicates were analyzed. Data are shown as mean ± SD. Antibodies used are indicated in [Table S1](#mmc1){ref-type="supplementary-material"}. SD, standard deviation.

AhR Deficiency Alters Metabolic Parameters Associated with Polyploidy and mTOR Activity {#sec2.5}
---------------------------------------------------------------------------------------

The PI3K-mTOR pathway has relevant functions in metabolism and energy control ([@bib67], [@bib81]). Recent work suggests that mTOR inhibition reduces glycolytic metabolism in polyploid cells ([@bib45]) and that amino acids such as L-Leu may regulate mTORC1 activity in certain forms of anemia ([@bib4], [@bib58]). We then performed metabolome analysis for amino acid content in serum from preweaning and adult *AhR+/+* and *AhR−/−* mice. Interestingly, L-Leu was significantly enriched in *AhR−/−* preweaning serum when compared with *AhR+/+* mice, although no significant changes were observed in adult mice ([Figure 7](#fig7){ref-type="fig"}C). L-Gln, which cooperates in transporting L-Leu into the cell, had also significantly higher levels in preweaning *AhR−/−* mice serum and a tendency of accumulation in adult AhR-null mice ([Figure 7](#fig7){ref-type="fig"}D). It is thus possible that L-Leu/L-Gln may contribute to mTORC1 activation in preweaning liver. We next did metabolomics for intermediates of the mitochondrial oxidative phosphorylation to determine whether reduced polyploidy in *AhR−/−* liver favors oxidative versus glycolytic metabolism. The results showed significant increases in serum levels of aerobic metabolism intermediates succinate, fumarate, and malate during the preweaning-to-adult transition in *AhR−/−* mice when compared with *AhR+/+* mice ([Figure 7](#fig7){ref-type="fig"}E), in agreement with the prominent roles of succinate (and to a lesser extent fumarate) in providing cellular energy and blocking senescence in replicative cells ([@bib12]), and with the preferred glycolytic metabolism found in high-ploidy cells ([@bib45]). Moreover, azelaic acid monoesters, which are negatively regulated by the hepatic carboxylesterase-3 (CES3) in an AhR-dependent manner and which could contribute to the liver steatosis present in very young *AhR−/−* mice ([@bib50]), were also markedly upregulated in preweaning *AhR−/−* liver, concomitantly to an inhibition of CES3 expression ([Figures 7](#fig7){ref-type="fig"}F and 7G).

Lack of Polyploidy in Adult AhR-Null Liver May Be Related to Centrosome Amplification {#sec2.6}
-------------------------------------------------------------------------------------

In the liver, developmental polyploidy may arise after several rounds of genome duplication in the absence of cytokinesis ([@bib56]), with the appearance of supernumerary centrosomes ([@bib13]). Interestingly, continued expression of endogenous AhR was shown to promote centrosome amplification (e.g., increased number of centrosomes) in breast cancer cells ([@bib39]). We considered the possibility that low-ploidy *AhR−/−* livers may have altered centrosome organization. Pericentrin (PCN), a prototypical component of the pericentriolar material (PCM) surrounding the centriole, was overexpressed in preweaning and adult *AhR−/−* livers with respect to *AhR+/+* liver, as determined by immunoblotting ([Figure 8](#fig8){ref-type="fig"}A). Confocal immunofluorescence in liver sections stained for PCN showed that, in the absence of AhR, adult hepatocytes appeared to have larger and strongly stained centrosomes than *AhR+/+* adult livers ([Figure 8](#fig8){ref-type="fig"}B). Image analyses were performed to quantify the area and volume of the centrosomes in *AhR+/+* and *AhR−/−* livers. In agreement, centrosomes of *AhR−/−* livers had larger areas ([Figure 8](#fig8){ref-type="fig"}C) and volumes ([Figure 8](#fig8){ref-type="fig"}D) than centrosomes in *AhR+/+* livers.Figure 8Lower Ploidy in *AhR−/−* Liver Could Be Associated with Altered Centrosome Composition(A) Total protein was obtained from preweaning and adult *AhR+/+* and *AhR−/−* liver and analyzed for pericentrin (PCN) expression by immunoblotting using a specific antibody.(B) Livers from adult *AhR+/+* and *AhR−/−* mice were fixed, embedded in paraffin, sectioned, and analyzed for PCN expression by immunofluorescence using a specific primary antibody and an Alexa 633-labeled secondary antibody. Sections were visualized using an Olympus FV1000 confocal microscope (Olympus). DAPI was used to label cell nuclei. Details of centrosomes at higher magnification are shown within yellow boxes on the right panels.(C and D) Centrosomal area (C) and PCN protein amount (D) were quantified using the ImageJ software, and the data show the different ranges in which centrosomes can be clustered for each mice genotype. β-Actin was used to confirm protein integrity and equal loading.Two representative mice for each condition are shown. Six mice for each developmental time and genotype and four technical replicates were analyzed. Data are shown as mean ± SD. Scale bar, 15 μm. Antibodies used are indicated in [Table S1](#mmc1){ref-type="supplementary-material"}. SD, standard deviation.

Pharmacological Inhibition of PI3K, ERK, and Wnt/β-Cat Signaling Partially Rescues Polyploidy in *AhR−/−* Liver {#sec2.7}
---------------------------------------------------------------------------------------------------------------

We next decided to investigate if inhibition of PI3K, ERK, and Wnt/β-Cat signaling could rescue polyploidy in *AhR−/−* liver ([Figure 9](#fig9){ref-type="fig"}). Primary hepatocytes were isolated from *AhR+/+* and *AhR−/−* mice by collagenase perfusion and cultured in the presence of pharmacological inhibitors LY294002 (PI3K), PD98059 (ERK), and salinomycin (Wnt/β-Cat). Inhibition of these signaling pathways increased the number of hepatocytes with 4c DNA content in both genotypes and interestingly, stimulated the appearance of *AhR−/−* hepatocytes with \>4c DNA content, including octaploid cells ([Figures 9](#fig9){ref-type="fig"}A and 9B).Figure 9Pharmacological Inhibition of PI3K, ERK, and Wnt/β-Cat Signaling Partially Rescues Polyploidy in *AhR−/−* Liver(A and B) Primary hepatocytes from *AhR+/+* (A) and *AhR−/−* (B) mice were cultured for 48 hr in the presence of inhibitors for PI3K (LY294002), ERK (PD98059), and Wnt/β-Cat (salinomycin) at a low or high concentration (see [Methods](#sec4){ref-type="sec"}). Their DNA content was analyzed by flow cytometry and represented as 2c, 4c, and \>4c containing cells.(C) *AhR−/−* mice were treated *in vivo* with those inhibitors (see [Methods](#sec4){ref-type="sec"}), and the activation of PI3K signaling determined by the levels of p-AKT^Ser473^ with respect to total AKT expression.(D) mTOR expression was also determined *in vivo* under the same experimental conditions indicated above.Two representative mice for each condition are shown. Six mice of each genotype were perfused to isolate primary hepatocytes for *in vitro* experiments and five mice were treated with inhibitors *in vivo*. Three technical replicates were analyzed. Data are shown as mean ± SD. Scale bar, 15 μm. Antibodies and oligonucleotides used are indicated in [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}, respectively. SD, standard deviation.

Treatment of *AhR−/−* mice with these inhibitors *in vivo* for 7 days reduced signaling through PI3K as determined by AKT phosphorylation at Ser473 ([Figure 9](#fig9){ref-type="fig"}C) and downregulated the expression of mTOR with respect to untreated AhR-null mice ([Figure 9](#fig9){ref-type="fig"}D). Overall, these *in vitro* and *in vivo* experiments support the involvement of PI3K, ERK, and Wnt/β-Cat signaling in liver polyploidization through a mechanism requiring AhR expression.

Discussion {#sec3}
==========

Taking into account that AhR expression promotes differentiation in different cell types ([@bib22], [@bib54]), and since polyploidization is in fact a differentiation process, we decided to investigate the role of AhR in the transition from a preweaning diploid liver to an adult polyploid liver and the signaling pathways that might be involved. The main conclusion from this work is that AhR maintains the activation of signaling pathways controlling proliferation, differentiation, and metabolism within physiological levels for proper liver polyploidization and maturation. The fact that several related pathways are modulated by AhR to control physiological liver polyploidy suggests that this receptor may be acting as a downstream hub in the signaling network. Future studies are guaranteed to determine the relative contribution of each of these pathways to the phenotype and the precise points for AhR interaction.

AhR deficiency increased the cellularity and reduced the average cell size in the preweaning proliferating liver and surprisingly, such hyperproliferative phenotype, rather than being blocked as in AhR wild-type mice, persisted in adult *AhR−/−* livers as demonstrated by Ki67 and PCNA immunodetection. These observations suggest that AhR is needed to maintain cell growth and proliferation within adequate physiological ranges in early stages of postnatal liver development. Even more, since the preweaning-to-adult transition involves a process of differentiation by which hepatocytes modify their cell cycle to inhibit division ([@bib10], [@bib72], [@bib83]), it appears likely that AhR is also required to switch from a proliferative to a differentiated adult liver. This hypothesis is supported by the fact that the liver differentiation marker albumin reached much higher expression levels in polyploid *AhR+/+* livers than in mostly diploid *AhR−/−* livers. In addition, it is also known that AhR is able to prevent mitotic progression, induce differentiation, and inhibit pluripotency in different cell types ([@bib15], [@bib22], [@bib37], [@bib53], [@bib54]).

Increased cell size, reduced proliferation, and terminal differentiation are common properties of polyploid cells including hepatocytes ([@bib14], [@bib63]). We therefore questioned whether AhR could be relevant for polyploidization of the adult liver. Indeed, AhR depletion maintained a predominantly diploid adult liver with a high content of mononuclear hepatocytes, suggestive of impaired polyploidy. To date, a sole single report has suggested that AhR may be needed for the differentiation and polyploidization of mouse megakaryocytes ([@bib44]). The existence of this common function of AhR in different unrelated cell types emphasizes that ploidy maintenance may be an evolutionary conserved role for this receptor along phylogeny. The implication of AhR in inducing differentiation and polyploidy was further supported by the fact that, in the absence of AhR, compromised polyploidy in adult mice was accompanied by upregulation of cell cycle proteins promoting transition through G1/S and G2/M, Cyclin B1 and Cyclin E, and repression of cell cycle inhibitors p27^Kip1^ and p21^Cip1^. Thus, adult mice liver polyploidy could involve physiological control of the cell cycle by a process requiring AhR expression. Consistently, since AhR can bind to inactive hypophosphorylated retinoblastoma protein (pRB) and to displace p300 from E2F promoters, AhR deficiency may result in enhanced proliferation in adult hepatocytes. Interestingly, lack of E2F8 transcription factor impairs polyploidization in mouse liver through overexpression of E2F-dependent target genes ([@bib57]), thus producing a phenotype similar to that present in AhR-null mice. Since the E2F8-deficient phenotype was associated with the upregulation of pro-cytokinesis genes, it might be relevant to address to what extent cytokinesis affects ploidy in *AhR−/−* mouse liver. It is intriguing that preweaning *AhR+/+* mice maintained higher levels of Cyclin B1 and Cyclin E despite their reduced proliferative potential with respect to *AhR−/−* mice. One possible explanation for these results is that wild-type livers overexpress positive regulators of the cell cycle to overcome their increased content in negative regulators p27^Kip1^ and p21^Cip1^.

Although the reduced polyploidy present in adult AhR-null liver could result from defective endoreplication ([@bib83]), it is also possible that the so-called ploidy reversal ([@bib19]) could generate cells of variable ploidy from a fraction of mature *AhR−/−* polyploid hepatocytes, ultimately restoring proliferative potential. Among the several molecular mechanisms driving polyploidy, failure to complete cytokinesis after mitosis appears relevant in mammalian liver ([@bib83]). We have found that the levels of PCN, a component of the PCM with relevant roles in spindle organization ([@bib84]), was restricted in centrosomes of AhR-expressing hepatocytes, suggesting that control of centrosomal activity by AhR may contribute to reduced proliferation and increased polyploidy. Since increased centrosome size appears related to a higher proliferative potential, adult diploid *AhR−/−* hepatocytes could enlarge their centrosomes to maintain proliferation in the absence of polyploidy. In addition, as PCN regulates mitotic responses in DNA damaged cells ([@bib1]), AhR-null hepatocytes could widen their centrosomes to complete cell division under enforced non-polyploid conditions, whereas polyploid AhR wild-type hepatocytes would keep an increased number of smaller centrosomes. Interestingly, lack of the E2F8 transcription factor in mouse liver promotes overexpression of E2F-dependent target genes and enhanced cytokinesis with impaired polyploidization ([@bib57]). Since such phenotype was related to the upregulation of pro-cytokinesis genes, it could be relevant to address whether pro-cytokinesis genes are also deregulated in *AhR−/−* mouse liver. In addition, altered E2F transcriptional activity could also be involved in the mechanism since AhR inhibits cell proliferation by repressing E2F-dependent transcription through p300 displacement.

Insulin hormone signals through the INS-R to PI3K and Ras-ERK pathways to control cell survival, proliferation, and metabolism ([@bib81]). A previous study has shown that AKT activation induced polyploidy in Wistar rat liver ([@bib11], [@bib10]). Our characterization of the INS-R/PI3K/AKT/GSK3β and ERK axes indicated that it was persistently downregulated from preweaning-to-adult *AhR+/+* liver when compared with AhR-deficient liver, suggesting that reduced signaling through those pathways may compromise proliferation and promote polyploid differentiation. In addition, diminished INS-R/PI3K/AKT/GSK3β and ERK signaling in polyploid AhR wild-type liver can be partly explained by the reduced insulin sensitivity of *AhR+/+* with respect to *AhR−/−* mice ([@bib77]). Remarkably, tumor suppressor p53, which is negatively regulated by PI3K signaling ([@bib66], [@bib80]), was downregulated in preweaning *AhR−/−* liver but overexpressed in adults. Nonetheless, p53 target gene p21^Cip1^ was consistently suppressed in AhR-null livers at either developmental stage. These apparently contradictory results can be explained in the context of p53-regulating ploidy ([@bib2], [@bib40]) or in the proposed p53-dependent versus p53-independent regulation of p21^Cip1^ ([@bib36], [@bib47]). Since previous work has indicated that p53 overexpression blocks polyploidy ([@bib2], [@bib40]), it can be suggested that high p53 expression impairs the diploid-to-polyploid transition in adult AhR-null liver, whereas a reduction in p53 levels could positively influence polyploidy in adult *AhR+/+* liver. In addition, p21^Cip1^ could be downregulated independently on p53 in AhR-null liver, as previously reported in *p53−/−* mouse ([@bib47]).

AhR cross talks with Wnt/β-Cat signaling as AhR activation represses Wnt/β-Cat-related tissue regeneration in zebrafish ([@bib49]), differentiation of liver progenitor cells ([@bib60]), and early differentiation of mouse embryonic stem cells ([@bib78]). On the other hand, Wnt/β-Cat signaling can increase the expression of AhR target genes in primary human hepatocytes ([@bib30]). Wnt/β-Cat signaling was significantly reduced in adult primary *AhR+/+* hepatocytes, suggesting in agreement with earlier data that inhibition of this pathway may contribute to polyploidization. An intriguing possibility is that AhR may be a component of the β-Cat repressive complex since both proteins co-immunoprecipitate under basal conditions in adult *AhR+/+* liver. It is thus plausible that the presence of AhR in the β-Cat complex negatively affects Wnt/β-Cat-dependent functions, including inhibition of cell proliferation. Since active p-AKT co-immunoprecipitated with β-Cat and such effect was more noticeable and sustained in *AhR−/−* than in *AhR+/+* liver, it is possible that cooperation between PI3K and Wnt/β-Cat supports liver proliferation and impairs polyploidy in the absence of AhR. Indeed, INS-R/PI3K can induce Wnt/β-Cat responses by inhibiting GSK3β ([@bib81]), which was repressed in adult *AhR−/−* liver.

PI3K/AKT, ERK, and Wnt/β-Cat pathways converge to regulate mTORC1, which is a major complex in controlling proliferation, survival, and metabolism ([@bib42], [@bib43], [@bib81]). Consistently, reduced activation of these pathways in preweaning and adult *AhR+/+* livers coincided with lower mTOR expression and diminished activation of its canonical target S6K1. Altogether, we propose that AhR-expressing hepatocytes inhibit signaling from PI3K/AKT, ERK, and Wnt/β-Cat to mTORC1 to block proliferation, induce differentiation, and trigger polyploidy during the preweaning-to-adult transition. In fact, expression of a kinase-dead form of S6K1 in megakaryocytes increases polyploidy, whereas its rapamycin-resistant active form decreased polyploidy ([@bib46]). mTORC1 also has relevant roles in cellular metabolism, and its activity can be increased by intracellular amino acids ([@bib9]). AhR expression reduced L-Leu and L-Gln levels in preweaning and L-Gln levels in adult liver. Since L-Leu and L-Gln are co-transported into the cell to activate mTORC1 ([@bib4], [@bib42], [@bib58]), it is possible that reduced L-Leu and L-Gln levels adversely affect mTORC1 in *AhR+/+* polyploid liver. Furthermore, high L-Gln levels in adult *AhR−/−* liver may depend on Wnt/β-Cat since this pathway regulates L-Gln metabolism in the liver ([@bib8]).

Polyploidization has been shown to favor glycolytic metabolism over mitochondrial oxidative phosphorylation in acute myeloid leukemia ([@bib45]). Polyploid, low-proliferating *AhR+/+* liver had reduced levels of succinate, considered the most energetic molecule of the mitochondrial aerobic metabolism ([@bib12]). This result suggests that polyploid adult AhR wild-type liver may have a preferred glycolytic energy demand and a more differentiated status than the diploid proliferative adult AhR-null liver that would favor a more energetic mitochondrial metabolism. Finally, preweaning *AhR+/+* livers had reduced levels of azelaic acid, likely due to overexpression of the AhR-regulated CES3 gene. Since high levels of azelaic acid have been associated with steatohepatitis ([@bib50]), these data could help explain the steatosis described in postnatal *AhR−/−* mice ([@bib69]).

We propose that AhR is needed to establish a physiological control of signaling pathways regulating cell proliferation, differentiation, metabolism, and polyploidy in mouse liver. This hypothesis is supported by the fact that inhibition of PI3K, ERK, and Wnt/β-Cat signaling rescues, at least partially, polyploidy in *AhR−/−* hepatocytes. Since polyploidization is a recurrent trait of human cancer ([@bib82]), understanding how AhR expression influences ploidy may provide novel therapeutic opportunities using non-toxic AhR modulators. Because the pathways identified here are regulated within the same developmental window, it seems reasonable that AhR acts downstream of mTOR, PKB, ERK, and β-Cat possibly by acting as a common intermediate. This may lead to identify novel nuclear and non-nuclear functions of AhR, as previously found for the regulation of caveolin-1, β1-integrin, and c-Src ([@bib21], [@bib65], [@bib64]). Elucidating whether ploidy reversal contributes to the reduced polyploidy of adult *AhR−/−* liver represents another relevant question that deserves further investigation.
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All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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